Lipoflex Special

Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonine, the active ingredients in Lipoflex Special, are amino acid supplements presented as an intravenous solution for intravenous use. It provides essential amino acids to support protein synthesis and metabolic processes in patients requiring nutritional support.

GNH USA supplies Lipoflex Special as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Lipoflex Special is used in clinical nutrition to address protein and amino‑acid deficiencies during parenteral feeding and catabolic stress. - Parenteral nutrition: supports protein synthesis in patients receiving total parenteral nutrition. - Post‑operative recovery: helps maintain nitrogen balance after major surgery. - Severe trauma or burns: provides essential amino acids during catabolic stress.

Adverse reactions may occur with intravenous amino‑acid administration.

Common Side Effects: - Infusion site irritation or phlebitis. - Mild nausea or vomiting. - Transient headache. - Hyperglycemia due to increased gluconeogenic substrate. - Electrolyte disturbances (e.g., mild hypokalemia). - Taste alteration or metallic mouthfeel.

Serious or Rare Side Effects: - Anaphylactic or severe hypersensitivity reactions. - Metabolic acidosis from amino‑acid overload. - Severe hyperammonemia, especially in hepatic impairment. - Acute renal dysfunction or oliguria. - Thrombophlebitis with prolonged catheter use. - Severe electrolyte imbalance (e.g., hypernatremia).

When using Lipoflex Special, clinicians should observe several safety measures. - Assess renal function: adjust therapy in patients with renal impairment. - Monitor electrolytes: watch for imbalances during infusion. - Check for hypersensitivity: discontinue immediately if allergic signs appear. - Use aseptic technique: prevent contamination of the intravenous line. - Pregnancy and lactation: consider risk‑benefit; data are limited. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potential drug interactions should be evaluated before initiating therapy.

Major Interactions (Avoid): - Concurrent high‑dose amino‑acid solutions with severe renal failure: risk of accumulation and toxicity. - Co‑administration with L‑asparaginase or other enzyme‑based chemotherapies: may reduce therapeutic efficacy. - Simultaneous insulin therapy: increased risk of hypoglycemia due to enhanced glucose utilization.

Moderate Interactions (Monitor Closely): - Use with diuretics: monitor electrolyte levels closely. - Combination with other parenteral nutrition components: adjust osmolarity and volume to avoid overload.